Advertisement

Topics

Sanofi Q2 Profit Declines, Sales Rise; Lifts FY17 Business EPS View

02:13 EDT 31 Jul 2017 | FinanzNachrichten

PARIS (dpa-AFX) - French drug giant Sanofi SA (SNYNF, SNY) reported Monday that its second-quarter IFRS net income attributable to equity holders of the company declined 10.4 percent to 1.04 billi...

Original Article: Sanofi Q2 Profit Declines, Sales Rise; Lifts FY17 Business EPS View

NEXT ARTICLE

More From BioPortfolio on "Sanofi Q2 Profit Declines, Sales Rise; Lifts FY17 Business EPS View"

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...